GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Meribank Biotech Co Ltd (ROCO:4724) » Definitions » Policy Acquisition Expense

Meribank Biotech Co (ROCO:4724) Policy Acquisition Expense


View and export this data going back to 2023. Start your Free Trial

What is Meribank Biotech Co Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Meribank Biotech Co (ROCO:4724) Business Description

Traded in Other Exchanges
N/A
Address
Sector 1, Neihu Road, 1st Floor, No.68, Neihu District, Taipei, TWN, 11493
Meribank Biotech Co Ltd is engaged in Research and development and sales of new cell drugs and also Umbilical cord blood, placenta and umbilical cord mesenchymal stem cells processing, testing and cryopreservation.